A61K 31/403
Condensed with carbocyclic rings
Official title: condensed with carbocyclic rings, e.g. carbazole
A61K31/403 (Condensed with carbocyclic rings) appears on 6,082 US grants and 11,204 published applications in this corpus.
Search patents in A61K- Granted patents
- 6,082
- Published applications
- 11,204
- Assignees
- 3,839
- Inventors
- 19,836
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 4 | 0 |
| 1978 | 6 | 0 |
| 1979 | 10 | 0 |
| 1980 | 13 | 0 |
| 1981 | 5 | 0 |
| 1982 | 6 | 0 |
| 1983 | 5 | 0 |
| 1984 | 7 | 0 |
| 1985 | 5 | 0 |
| 1986 | 2 | 0 |
| 1987 | 9 | 0 |
| 1988 | 12 | 0 |
| 1989 | 8 | 0 |
| 1990 | 18 | 0 |
| 1991 | 12 | 0 |
| 1992 | 12 | 0 |
| 1993 | 20 | 0 |
| 1994 | 13 | 0 |
| 1995 | 22 | 0 |
| 1996 | 48 | 0 |
| 1997 | 100 | 0 |
| 1998 | 81 | 0 |
| 1999 | 106 | 0 |
| 2000 | 101 | 0 |
| 2001 | 108 | 63 |
| 2002 | 137 | 207 |
| 2003 | 104 | 291 |
| 2004 | 92 | 334 |
| 2005 | 66 | 278 |
| 2006 | 126 | 296 |
| 2007 | 83 | 313 |
| 2008 | 90 | 291 |
| 2009 | 88 | 297 |
| 2010 | 103 | 305 |
| 2011 | 118 | 315 |
| 2012 | 121 | 320 |
| 2013 | 194 | 435 |
| 2014 | 256 | 537 |
| 2015 | 290 | 539 |
| 2016 | 320 | 558 |
| 2017 | 356 | 571 |
| 2018 | 362 | 537 |
| 2019 | 390 | 532 |
| 2020 | 345 | 567 |
| 2021 | 315 | 562 |
| 2022 | 320 | 660 |
| 2023 | 295 | 677 |
| 2024 | 295 | 631 |
| 2025 | 274 | 619 |
| 2026 | 205 | 469 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method and apparatus for delivering an API-containing liquid to an edible substrate6 Oct 2026US 12,751,915 B2Transport Authority, Inc.
- Methods for delivery of psychedelic medications by inhalation and systems for performing the methods6 Oct 2026US 12,751,940 B2Cybin IRL Limited
- Methods of treating fibrotic liver diseases or conditions with indeglitazar29 Sep 2026US 12,746,225 B2Pleiogenix Inc.
- Pharmaceutical kits and uses thereof for treating colorectal cancer29 Sep 2026US 12,746,226 B2Anbogen Therapeutics, Inc
- Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations29 Sep 2026US 12,746,268 B2Nymox Corporation
- Method and pharmaceutical composition for treating a sleep disorder8 Oct 2026US 2026/0306442 A1Overseas Pharmaceuticals, Ltd.
- Methods for using bacteria and host/microbiota-derived metabolites for diagnosis and treatment of endometriosis8 Oct 2026US 2026/0306451 A1Baylor College of Medicine
- 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) pharmaceutical compositions8 Oct 2026US 2026/0306452 A1Beckley Psytech Limited
- Formulations containing tryptamine derivatives and uses thereof8 Oct 2026US 2026/0306453 A1Psilera Inc.
- N-n-dimethyltryptamine (dmt) and dmt analog oral transmucosal film compositions, methods of making, and methods of use thereof8 Oct 2026US 2026/0306454 A1
Most cited
By later US patents
- Method of treating androgen independent prostate cancer1,091US 9,040,574 B2Natrogen Therapeutics International, Inc. · 2015
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015
- Therapeutic inhibitor of vascular smooth muscle cells562US 5,733,925 ANeoRx Corporation · 1998
- Therapeutic inhibitor of vascular smooth muscle cells438US 5,981,568 ANeoRx Corporation · 1999
- Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use354US 5,091,171 A1992